Luca Zanin

Dr. Luca Zanin

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 May 2020 in Acta Neurochirurgica
Verified
Journal Article
Closed access
PDF file
LZLuca Zanin
Luca Zanin
GSGiorgio Saraceno
Giorgio Saraceno
PPPier Paolo Panciani
Pier Paolo Panciani
GRGiulia Renisi
Giulia Renisi
LSLiana Signorini
Liana Signorini
Marco Maria FontanellaMarco Maria Fontanella
Marco Maria Fontanella

1 July 2020 in World Neurosurgery
Verified
Journal Article
Closed access
Marco Maria FontanellaMarco Maria Fontanella
Marco Maria Fontanella
LMLucio De Maria
Lucio De Maria
LZLuca Zanin
Luca Zanin
GSGiorgio Saraceno
Giorgio Saraceno
LBLodovico Terzi di Bergamo
Lodovico Terzi di Bergamo
FDFrancesco Doglietto
Francesco Doglietto

1 July 2020 in Brain, Behavior, and Immunity
Verified
Journal Article
Closed access
PPPier Paolo Panciani
Pier Paolo Panciani
GSGiorgio Saraceno
Giorgio Saraceno
LZLuca Zanin
Luca Zanin
GRGiulia Renisi
Giulia Renisi
LSLiana Signorini
Liana Signorini
Marco Maria FontanellaMarco Maria Fontanella
Marco Maria Fontanella

18 May 2023 in Biology
Verified
Journal Article
Open access
PDF file
Edoardo AgostiEdoardo Agosti
Edoardo Agosti
PPPier Paolo Panciani
Pier Paolo Panciani
Marco ZeppieriMarco Zeppieri
Marco Zeppieri
LMLucio De Maria
Lucio De Maria
FPFrancesco Pasqualetti
Francesco Pasqualetti
Tamara IusTamara Ius
Tamara Ius
The invasive nature of glioblastoma is problematic in a radical surgery approach and can be responsible for tumor recurrence. In order to create new therapeutic strategies, it is imperative to have a better understanding of the mechanisms behind tumor growth and invasion. The continuous cross-talk between glioma stem cells (GSCs) and the tumor microenvironment (TME) contributes to disease progression, which renders research in this field difficult and challenging. The main aim of the review was to assess the different possible mechanisms that could explain resistance to treatment promoted by TME and GSCs in glioblastoma, including the role of M2 macrophages, micro RNAs (miRNAs), and long non-coding RNAs (lncRNAs) from exosomes from the TME. A systematic review of the literature on the role of the TME in developing and promoting radioresistance and chemoresistance of GBM was performed according to PRISMA-P (Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols) guidelines. A dedicated literature review search was also performed on the immunotherapeutic agents against the immune TME. We identified 367 papers using the reported keywords. The final qualitative analysis was conducted on 25 studies. A growing amount of evidence in the current literature supports the role of M2 macrophages and non-coding RNAs in promoting the mechanisms of chemo and radioresistance. A better insight into how GBM cells interact with TME is an essential step towards comprehending the mechanisms that give rise to resistance to standard treatment, which can help to pave the way for the development of novel therapeutic strategies for GBM patients.

18 April 2020 in Neurosurgery
Verified
Journal Article
Open access
PDF file
PPPier Paolo Panciani
Pier Paolo Panciani
GSGiorgio Saraceno
Giorgio Saraceno
LZLuca Zanin
Luca Zanin
GRGiulia Renisi
Giulia Renisi
LSLiana Signorini
Liana Signorini
Marco Maria FontanellaMarco Maria Fontanella
Marco Maria Fontanella

1 August 2020 in Clinical Neurology and Neurosurgery
Verified
Journal Article
Closed access
FBFrancesco Belotti
Francesco Belotti
LZLuca Zanin
Luca Zanin
Marco Maria FontanellaMarco Maria Fontanella
Marco Maria Fontanella
PPPier Paolo Panciani
Pier Paolo Panciani